Alleviating Effect of Lacticaseibacillus rhamnosus 1.0320 Combined with Dihydromyricetin on Acute Alcohol Exposure-Induced Hepatic Impairment: Based on Short-Chain Fatty Acids and Adenosine 5'-Monophosphate-Activated Protein Kinase-Mediated Lipid Metabolism Signaling Pathway

J Agric Food Chem. 2023 Mar 29;71(12):4837-4850. doi: 10.1021/acs.jafc.2c08523. Epub 2023 Mar 17.

Abstract

Excessive drinking has been listed by the World Health Organization as the fifth major risk factor; especially the liver, as the core organ of alcohol metabolism, is prone to organic lesions. Probiotics have received attention due to their bioactivity for liver protection. The beneficial effects of probiotics on hosts are related to their physiological functions. Therefore, based on the concept of second-generation synbiotes, this study explored the protective effects of four dietary polyphenols on the stress tolerance, hydrophobicity, adhesion, and digestive characteristics of L. rhamnosus 1.0320. L. rhamnosus 1.0320 had the best synergistic effect with dihydromyricetin (DMY). Therefore, this combination was selected as a synbiotic supplement to explore the protective effect on acute alcohol exposure-induced hepatic impairment. The results showed that L. rhamnosus 1.0320 combined with DMY restored the intestinal barrier by upregulating short-chain fatty acid levels and activated the adenosine 5'-monophosphate-activated protein kinase-mediated lipid metabolism pathway to inhibit oxidative stress, inflammation, and lipid accumulation in the liver. Furthermore, 109 CFU/mouse/d L. rhamnosus 1.0320 and 50 mg/kg/d DMY by gavage were identified as the optimal doses for protection against acute alcohol expose-induced hepatic impairment. This study provides new insights into alleviating acute alcoholic hepatic impairment by targeting intestinal metabolites through the gut-liver axis.

Keywords: alcoholic liver disease; inflammation; lipid accumulation; oxidative stress; synbiotics.

MeSH terms

  • Adenosine / metabolism
  • Animals
  • Ethanol / metabolism
  • Fatty Acids, Volatile / metabolism
  • Lacticaseibacillus
  • Lacticaseibacillus rhamnosus*
  • Lipid Metabolism
  • Liver / metabolism
  • Liver Diseases, Alcoholic* / drug therapy
  • Liver Diseases, Alcoholic* / metabolism
  • Liver Diseases, Alcoholic* / prevention & control
  • Mice
  • Probiotics*
  • Protein Kinases / metabolism
  • Signal Transduction

Substances

  • dihydromyricetin
  • Protein Kinases
  • Ethanol
  • Fatty Acids, Volatile
  • Adenosine